Central Admixture Pharmacy Services, Inc.
Irvine, CA Doing business as Caps
- UEI
- NDPWXJSVYVH9
- CAGE
- 3S5G9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- PA QNSRGPYZE3Z9
- Bethlehem, PA CFRKPMXBZ6X7
- Bethlehem, PA KC45M3TJ8XM5
-
- SAM.gov registration date
- Physical address
- 6430 Oak Canyon #200, Irvine, CA 92618, USA
- Website
- capspharmacy.com
- Founded
- 1991
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,851,329 |
| FY2025 | $817,758 |
| FY2024 | $2,846,540 |
| FY2023 | $1,660,731 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $1,282,198 | |
| 2 | Department of Health and Human Services | $319,131 | |
| 3 | Defense Health Agency | $250,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fagron Sterile Services | Wichita, KS | 325412 Pharmaceutical Preparation Manufacturing |
| Quva Pharma, Inc. | Sugar Land, TX | 325412 Pharmaceutical Preparation Manufacturing |
| Avella Of Deer Valley, Inc #038 - Cancelled | Phoenix, AZ | 621610 Home Health Care Services |
| Optum Infusion Services 308, LLC | Chandler, AZ | 621610 Home Health Care Services |
| Hygen Pharmaceuticals Inc. | Redmond, WA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Central Admixture Pharmacy Services, Inc., doing business as Caps, manufactures and delivers compounded sterile pharmaceutical preparations—total parenteral nutrition solutions, intravenous admixtures, lipid emulsions, and cardioplegia orders—to federal healthcare agencies as a large-business prime contractor operating under full-and-open competition with no set-aside posture. Headquartered in Irvine, California, Caps is a for-profit organization operating as both a 503A traditional pharmacy and 503B outsourcing facility under primary NAICS 325412 (Pharmaceutical Preparation Manufacturing), with 762 prime federal contract awards spanning healthcare delivery across the Department of Veterans Affairs, Defense Health Agency, National Institutes of Health, Department of the Navy, Indian Health Service, and Department of the Army Medical Command.
Caps' customer concentration anchors to the Defense Health Agency (26 awards, $17.6 million combined potential value) and the NIH Clinical Center (18 awards, $15.7 million), which together with the Department of the Navy Bureau of Medicine and Surgery (33 awards, $11.4 million), VA VISN 10 (33 awards, $8.8 million), and VA VISN 22 (24 awards, $7.3 million) represent 73 percent of combined potential value across all awards. Caps competes predominantly as a direct supplier to individual VISNs and healthcare agencies rather than consolidating activity under agency-wide vehicles; the top parent vehicles are departmental IDIQs such as VISN 10's single-award $826 thousand contract for TPN and cardioplegia solutions at the LTC Charles S. Kettles VA Medical Center and VISN 22's $4 million single-award contract for total parenteral nutrition supplies, each of which has generated multiple task orders over multi-year periods. Work is performed at Caps' Irvine, California facility and at customer locations (Cleveland, Ohio; Kansas City, Missouri; Tampa, Miami, and West Palm Beach, Florida; San Diego and Los Angeles, California; and Bethesda, Maryland), with same-day delivery requirements met through established logistics.
Recent representative awards illustrate scope: a $350 thousand purchase order from NIH Clinical Center (May 2026) for compounding services; a $624 thousand purchase order from VA VISN 8 (October 2024) for total parenteral nutrition bags with 24-hour delivery to the West Palm Beach VA Healthcare System through September 2029; a $4 million single-award IDIQ from VA VISN 22 (September 2024) for total parenteral nutrition supplies through September 2027, from which eight delivery orders have been issued ranging from $54 thousand to $217 thousand; and multiple firm fixed-price delivery orders from the Defense Health Agency for sterile admixture products to military medical centers including Alexander T. Augusta Military Medical Center and Walter Reed National Military Medical Center. Activity is stable: 19 awards in 2022, 10 in 2023, 19 in 2024, 12 in 2025, and 10 year-to-date in 2026. Eleven awards with combined potential value of $2.4 million reach ultimate completion in the next twenty-four months and represent recompete exposure. Caps maintains zero subcontract footprint and competes exclusively as a prime contractor with no named teaming relationships in the source material. The vendor holds no position on government-wide GWACs or agency-wide IDIQs; all parent vehicles are departmental single-award contracts held directly with individual VISNs or agency components.
Quick answers
Is Central Admixture Pharmacy Services, Inc. registered in SAM.gov?
Yes. Central Admixture Pharmacy Services, Inc.'s SAM.gov registration is active through October 31, 2026.
How much has Central Admixture Pharmacy Services, Inc. received in federal contracts?
Federal contracts obligated $817,758 to Central Admixture Pharmacy Services, Inc. in fiscal year 2025 and $7,176,358 in fiscal years 2023 through 2027.
How does Central Admixture Pharmacy Services, Inc. rank among federal contractors?
Central Admixture Pharmacy Services, Inc. ranked #47 in PSC Q517, #75 in NAICS 325412 and #99 in PSC 6505 in FY2025.
What is Central Admixture Pharmacy Services, Inc.'s most recent federal award?
Central Admixture Pharmacy Services, Inc.'s most recent federal contract award is Pharmacy compounding services for total parenteral nutrition. Order for OY 2 (36C25026N0733), from Veterans Integrated Service Network 10 (VHA), on September 30, 2026.
On GovTribe
See Central Admixture Pharmacy Services, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors